OTC Chronic Drug Compliance Abetted By Interactive Tools
This article was originally published in The Tan Sheet
Executive Summary
Personalized, interactive materials are most successful at ensuring consumer compliance with chronic drug regimens, according to Saul Shiffman, PhD, University of Pittsburgh
You may also be interested in...
Third Class Of Drugs Should Not Be “Completely Closed Down” – Ganley
Debate on the merits of a third class of drugs could resurface as FDA considers Rx-to-OTC switch applications of drugs indicated for chronic conditions
Chronic Condition OTC Mass Marketing Ineffective - Consultant
OTC switches of chronic condition drugs will necessitate a move away from the traditional mass marketing mindset to more targeted promotional approaches, NCI Consulting President Susan Lavine Coleman said at an Institute for International Research forum in New York June 11.
Toll-Free Screening, Advice Service Would Enchance OTC Mevacor - Merck
Merck would support an OTC version of its statin drug Mevacor with an ambitious customer education program that would ensure proper usage of the cholesterol-lowering medication, the firm stated July 13 at a joint meeting of FDA's Nonprescription and Endocrinologic & Metabolic Drugs Advisory Committees.